Pharmaceuticals

Excellence, Resilience, and Innovation: Navigating the tensions of the Pharmaceutical Industry

The pharmaceutical industry is undergoing an unprecedented transformation driven by evolving healthcare requirements and regulations, demographic shifts, technological advancements, and increasingly fragile supply chains. Adapting to changing circumstances, such as those seen during the COVID-19 pandemic, requires strategic foresight, operational excellence, and agile approaches tailored to the unique challenges of the pharmaceutical sector.

Current situation in the industry

01

Strategic Supply Chain and Alliance Management

Effective supply chain management is crucial for pharmaceutical companies to ensure timely product delivery, manage inventory, and particularly mitigate risks in the supply chain. Our approach involves assessing supply chain vulnerabilities, diversifying procurement options, and establishing strategic partnerships. By enhancing transparency, agility, and resilience in supply chains, companies can minimize disruptions and maintain delivery continuity.

Ensuring a stable supply chain is crucial, especially in the pharmaceutical industry. The availability and quality of raw materials are crucial for maintaining competitiveness. Through strategic supplier relationship management, demand forecasting, and risk mitigation strategies, we help our clients manage the complexity and compliance of the supply chain and ensure product availability.

Christian Müller

Christian Müller

Senior Director
02

Operational Excellence in Manufacturing

Maximizing operational efficiency in pharmaceutical manufacturing is essential to meet increasing demand. At the same time, strict product quality requirements and compliance with regulations needs to be ensured. Our approach focuses on optimizing production processes, implementing advanced manufacturing technologies, and introducing Lean Manufacturing principles. By streamlining operations and reducing non-value-added activities, pharmaceutical companies can increase productivity, reduce costs, and enhance competitiveness.

We support the entire production process. Through advanced process optimization, automation, and continuous improvement initiatives, we help pharmaceutical companies achieve operational excellence and meet evolving market demands while maintaining the highest product quality.

Dominik Weiß

Dominik Weiß

Managing Director

Success stories

  • Mechanical/plant engineering

    Repositioning a market leader

    FTI-Andersch supported the management under the leadership of Ralf Haspel with precise analysis and global strategy to sustainable turnaround and increased company value.

    More

  • In addition to the high level of commitment and professionalism, I particularly appreciated the focus and the efficiency of the collaboration with FTI-Andersch. Within a short period of time, the team clearly worked out the core statements and thus decisively contributed to the stability of the financing process.

    Xu Tao

    Xu Tao

    Group CFO, Pacoma, Manufacturer of hydraulic cylinders
  • Industrial equipment supplier

    FTI-Andersch supported MAX Automation in the refinancing of the existing syndicated financing in the amount of € 190 million and contributed to the success of the negotiations through targeted analyses and presentations as well as content-related input. During the mandate, the cooperation was always characterised by mutual trust, openness and professionalism.

    Dr. Christian Diekmann

    Dr. Christian Diekmann

    CEO/CFO, MAX Automation, Industrial equipment supplier
  • Industrial Automation and Trade

    The FTI-Andersch team has always supported us in a solution-oriented, pragmatic and efficient manner. Together we managed to realise the necessary refinancing. This has brought our company forward sustainably.

    Richard Mayer

    Richard Mayer

    Geschäftsführer/CFO, Blumenbecker, Industrial automation and trade
  • Consistent performance increase

    The team at FTI-Andersch worked in partnership to support us in reviewing our ways of working in the plants, our site network and the existing Operational Excellence program. The findings from the project were jointly reflected upon and integrated into the existing performance improvement program. To guarantee transparent and quantifiable implementation, FTI-Andersch actively supported us in implementing a program management organization.

    Michael Lindner

    Michael Lindner

    Board of Directors (Production), Linde + Wiemann, Automotive Supplier

What challenges does the pharmaceutical industry face, Mike Zöller?

How does the pharmaceutical industry adapt to technological trends and market shifts?

Especially during the COVID-19 pandemic, the pharmaceutical industry demonstrated its efficiency and adaptability. Particularly agile and operationally flexible companies benefited. Therefore, our focus lies on operational excellence in manufacturing and strategic supply chain management, enabling pharmaceutical companies to effectively cope with disruptions in the industry and capitalize on emerging trends and regulatory changes.

Has the pandemic influenced structural changes in the industry?

The pandemic has highlighted the importance of operational resilience, supply chain agility, and compliance with regulations in the pharmaceutical industry. Our focus is on supporting companies to strengthen their manufacturing capacities, optimize processes in the supply chain, and ensure compliance with regulations to adapt to market dynamics. Through proactive risk management strategies and strategic transformation initiatives tailored to the pharmaceutical industry, companies can mitigate the impacts of external disruptions and emerge strengthened from a post-pandemic landscape.

Your Contacts

How we help our clients

All services

All industries